Longitudinal study comparing IgG antibodies induced by heterologous prime‐boost COVID‐19 vaccine
J Med Virol; 95 (1), 2023
ABSTRACT: Vaccines are critical cost‐effective tools to control the COVID‐19 pandemic. The heterologous prime‐boost vaccination has been used by many countries to overcome supply issues, so the effectiveness and safety of this strategy need to be better clarified. This study aims to verify the effe...